Healthcare -
Biotechnology - NASDAQ - US
$ 9.75
0.619 %
$ 752 M
Market Cap
-3.18
P/E
REPL - CASH FROM OPERATIONS
Cash from Operations REPL - Replimune Group, Inc.
-185 M
LAST VALUE
-50.23%
2 YEAR CAGR
-48.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR